Isolation of primary immune cells from fibrotic skin, esophageal, and gut tissue.
Steele, H; Song, B; Willicut, A; Grimes, HL; Herro, R.
Journal of Immunological Methods.
2021;
497.
Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders.
Steele, H; Sachen, K; McKnight, AJ; Soloff, R; Herro, R.
Frontiers in Immunology.
2021;
12.
Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype.
Manresa, MC; Chiang, AW T; Kurten, RC; Dohil, R; Brickner, H; Dohil, L; Herro, R; Akuthota, P; Lewis, NE; Croft, M; et al.
Gastroenterology.
2020;
159:1778-1792.e13.
TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling.
Herro, R; Miki, H; Sethi, GS; Mills, D; Mehta, AK; Nguyen, X; Feghali-Bostwick, C; Miller, M; Broide, DH; Soloff, R; et al.
Journal of Immunology.
2020;
205:2414-2422.
Adenosine deaminase-1 delineates human follicular helper T cell function and is altered with HIV.
Tardif, V; Muir, R; Cubas, R; Chakhtoura, M; Wilkinson, P; Metcalf, T; Herro, R; Haddad, EK.
Nature Communications.
2019;
10.
The TWEAK/Fn14 pathway is required for calcineurin inhibitor toxicity of the kidneys.
Claus, M; Herro, R; Wolf, D; Buscher, K; Rudloff, S; Huynh-Do, U; Burkly, L; Croft, M; Sidler, D.
American Journal of Transplantation.
2018;
18:1636-1645.
LIGHT-HVEM signaling in keratinocytes controls development of dermatitis.
Herro, R; Shui, J; Zahner, S; Sidler, D; Kawakami, Y; Kawakami, T; Tamada, K; Kronenberg, M; Croft, M.
Journal of Experimental Medicine.
2018;
215:415-422.